|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Weisenberger DJ, Liang G and Lenz HJ: DNA
methylation aberrancies delineate clinically distinct subsets of
colorectal cancer and provide novel targets for epigenetic
therapies. Oncogene. 37:566–577. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wong CC, Li W, Chan B and Yu J: Epigenomic
biomarkers for prognostication and diagnosis of gastrointestinal
cancers. Semin Cancer Biol. 55:90–105. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Du Z, Fei T, Verhaak RG, Su Z, Zhang Y,
Brown M, Chen Y and Liu XS: Integrative genomic analyses reveal
clinically relevant long non-coding RNAs in human cancer. Nat
Struct Mol Biol. 20:908–913. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tse JWT, Jenkins LJ, Chionh F and
Mariadason JM: Aberrant DNA methylation in colorectal cancer: What
should we target? Trends Cancer. 3:698–712. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kim MS, Lee J and Sidransky D: DNA
methylation markers in colorectal cancer. Cancer Metastasis Rev.
29:181–206. 2010.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Wang Z, Yang B, Zhang M, Guo W, Wu Z, Wang
Y, Jia L, Li S, Cancer Genome Atlas Research Network , Xie W
and Yang D: lncRNA epigenetic landscape analysis identifies EPIC1 as
an oncogenic lncRNA that interacts with MYC and promotes cell-cycle
progression in cancer. Cancer Cell. 33:706–720.e9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Toyota M, Ahuja N, Ohe-Toyota M, Herman
JG, Baylin SB and Issa JP: CpG island methylator phenotype in
colorectal cancer. Proc Natl Acad Sci USA. 96:8681–8686.
1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer. Nature
487: 330.337, 2012.
|
|
11
|
Cancer Genome Atlas Research Network:
Comprehensive molecular characterization of gastric adenocarcinoma.
Nature 513: 202.209, 2014.
|
|
12
|
Barretina J, Caponigro G, Stransky N,
Venkatesan K, Margolin AA, Kim S, Wilson CJ, Lehár J, Kryukov GV,
Sonkin D, et al: The cancer cell line encyclopedia enables
predictive modelling of anticancer drug sensitivity. Nature.
483:603–607. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kamburov A, Wierling C, Lehrach H and
Herwig R: ConsensusPathDB-a database for integrating human
functional interaction networks. Nucleic Acids Res. 37:D623–D628.
2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Sanford T, Meng MV, Railkar R, Agarwal PK
and Porten SP: Integrative analysis of the epigenetic basis of
muscle-invasive urothelial carcinoma. Clin Epigenetics.
10(19)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gevaert O: MethylMix: An R package for
identifying DNA methylation-driven genes. Bioinformatics.
31:1839–1841. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Indrajeet Patil: ‘ggplot2’ Based Plots
with Statistical Details (R package ggstatsplot version 0.0.1).
2018.
|
|
17
|
Wickham H: Ggplot2: Elegant Graphics for
Data Analysis. J R Stat Soc. 174:245–246. 2011.
|
|
18
|
Xu RH, Wei W, Krawczyk M, Wang W, Luo H,
Flagg K, Yi S, Shi W, Quan Q, Li K, et al: Circulating tumour DNA
methylation markers for diagnosis and prognosis of hepatocellular
carcinoma. Nat Mater. 16:1155–1161. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Ma C, Rong Y, Radiloff DR, Datto MB,
Centeno B, Bao S, Cheng AW, Lin F, Jiang S, Yeatman TJ and Wang XF:
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of
colon cancer by enhancing cell extravasation. Genes Dev.
22:308–321. 2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Yokobori T and Nishiyama M: TGF-β
signaling in gastrointestinal cancers: Progress in basic and
clinical research. J Clin Med. 6(E11)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang H, Dong S and Feng J: Epigenetic
profiling and mRNA expression reveal candidate genes as biomarkers
for colorectal cancer. J Cell Biochem. 120:10767–10776.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yue X, Ai J, Xu Y, Chen Y, Huang M, Yang
X, Hu B, Zhang H, He C, Yang X, et al: Polymeric immunoglobulin
receptor promotes tumor growth in hepatocellular carcinoma.
Hepatology. 65:1948–1962. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Richard Fristedt, Jacob Elebro, Alexander
Gaber, Björn Nodin, Mathias Uhlén and Karin Jirström: Abstract B30:
High expression of PIGR is an independent favorable prognostic
factor in pancreatic and periampullary adenocarcinoma. Cancer Res.
75:B30. 2015.
|
|
24
|
Bhatlekar S, Fields JZ and Boman BM: HOX
genes and their role in the development of human cancers. J Mol Med
(Berl). 92:811–823. 2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W
and Yuan Z: Up-regulation of bone marrow stromal protein 2 (BST2)
in breast cancer with bone metastasis. BMC Cancer.
9(102)2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pan XB, Qu XW, Jiang D, Zhao XL, Han JC
and Wei L: BST2/Tetherin inhibits hepatitis C virus production in
human hepatoma cells. Antiviral Res. 98:54–60. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chiang SF, Kan CY, Hsiao YC, Tang R, Hsieh
LL, Chiang JM, Tsai WS, Yeh CY, Hsieh PS, Liang Y, et al: Bone
marrow stromal antigen 2 is a novel plasma biomarker and
prognosticator for colorectal carcinoma: A secretome-based
verification study. Dis Markers. 2015(874054)2015.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Mukai S, Oue N, Oshima T, Mukai R,
Tatsumoto Y, Sakamoto N, Sentani K, Tanabe K, Egi H, Hinoi T, et
al: Overexpression of transmembrane protein BST2 is associated with
poor survival of patients with esophageal, gastric, or colorectal
cancer. Ann Surg Oncol. 24:594–602. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gallego-Ortega D, Ledger A, Roden DL, Law
AM, Magenau A, Kikhtyak Z, Cho C, Allerdice SL, Lee HJ, Valdes-Mora
F, et al: ELF5 drives lung metastasis in luminal breast cancer
through recruitment of Gr1+ CD11b+
myeloid-derived suppressor cells. PLoS Biol.
13(e1002330)2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yao B, Zhao J, Li Y, Li H, Hu Z, Pan P,
Zhang Y, Du E, Liu R and Xu Y: Elf5 inhibits TGF-β-driven
epithelial-mesenchymal transition in prostate cancer by repressing
SMAD3 activation. Prostate. 75:872–882. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
O'Reilly JA, Fitzgerald J, Fitzgerald S,
Kenny D, Kay EW, O'Kennedy R and Kijanka GS: Diagnostic potential
of zinc finger protein-specific autoantibodies and associated
linear B-cell epitopes in colorectal cancer. PLoS One.
10(e0123469)2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Gaykalova DA, Vatapalli R, Wei Y, Tsai HL,
Wang H, Zhang C, Hennessey PT, Guo T, Tan M, Li R, et al: Outlier
analysis defines zinc finger gene family DNA methylation in tumors
and saliva of head and neck cancer patients. PLoS One.
10(e0142148)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Hinoue T, Weisenberger DJ, Lange CP, Shen
H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk
CM, et al: Genome-scale analysis of aberrant DNA methylation in
colorectal cancer. Genome Res. 22:271–282. 2012.PubMed/NCBI View Article : Google Scholar
|
